2026-04-14T03:20:17Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1782422025-12-05T04:24:31Zcom_2072_1057col_2072_478809col_2072_478917

Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018) Darbà, Josep Marsà, Alícia Cost de l'assistència sanitària Gestió hospitalària Hepatitis Malalties del fetge Cost of medical care Hospital administration Hepatitis Liver diseases Intrahepatic cholangiocarcinomas (iCCA) are aggressive tumors, often diagnosed in advanced stages and with limited curative treatment options. Their incidence has raised in the past years, increasing their associated economic burden. This study aimed to measure hospital incidence and mortality of iCCA and to evaluate direct medical costs. 2021-06-10T20:45:48Z 2022-05-04T05:10:21Z 2021-05-04 2021-06-10T20:45:49Z info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion 1473-7167 https://hdl.handle.net/2445/178242 703978 eng Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1842201 Expert Review of Pharmacoeconomics & Outcomes Research, 2021, vol. 21, núm. 3, p. 425-431 https://doi.org/10.1080/14737167.2021.1842201 (c) Informa Healthcare, 2021 info:eu-repo/semantics/openAccess -3822 p. application/pdf Informa Healthcare Articles publicats en revistes (Economia)